The growing demand for precise immunological study and therapeutic development has spurred significant advances in recombinant growth factor generation. IL-1A, IL-1B, IL-2, and IL-3, each possessing unique physiological roles, are frequently manufactured using multiple expression methods, including microbial hosts, mammalian cell populations, and b